FOR IMMEDIATE RELEASE
Modulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
Modulus Discovery Inc. (“Modulus”), a pre-clinical stage technology-driven drug discovery company announced today that it was invited to present at the 39th Annual J.P. Morgan Healthcare Conference in January 2021. The J.P. Morgan Healthcare Conference, which attracts over 500 companies and 12,000 investors, is going virtual for 2021, and the webcast will be made available online following the live event.
S. Roy Kimura, co-founder and CEO, will present on January 12, 2021 at 8:40 AM EST and will give a brief introduction to the company’s cutting edge simulation-based drug discovery platform and its maturing portfolio of small-molecule drug discovery projects in chronic inflammation, oncology, and infectious diseases including COVID and related RNA viruses. Following the event, the company will be available for meetings with interested parties to further describe its unique discovery platform and capabilities and lead programs currently in pre-clinical studies.
Comment from S. Roy Kimura, CEO, Modulus Discovery, Inc.
“We are delighted to be given this opportunity to introduce our company’s technology platform, small-molecule discovery capabilities, and unique portfolio of R&D programs. Our lead programs targeting chronic inflammation / autoimmune diseases and oncology are currently approaching the IND stage, and we would be happy to provide information about them to interested parties for potential clinical partnerships.”
〈About Modulus Discovery, Inc.〉
Modulus Discovery, Inc., is a preclinical-stage technology-driven drug discovery firm with offices in Tokyo and Boston. The company is pursuing its portfolio of small-molecule discovery programs and collaborations through integration of its unique core biology insights, cutting-edge simulation platform, and scalable networked operations. Modulus is focused on the efficient delivery of breakthrough medicines for patients and their families with unmet medical needs in areas including oncology, chronic inflammation / immune disorders, infectious diseases, and rare genetic conditions.
If you’d like more information about this topic, please email at firstname.lastname@example.org